Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-(nitrooxy)butyl-(2s)-2-(6-methoxy-2-naphthyl)propanoate
2. Azd 3582
3. Azd-3582
4. Azd3582
5. Naproxen-n-butyl Nitrate
6. Nicox
7. Nitric Oxide Naproxen
8. Nitric Oxide-releasing Naproxen
9. No-naproxen
1. 163133-43-5
2. Nitronaproxen
3. Naproxen-n-butyl Nitrate
4. Hct 3012
5. Azd3582
6. No-naproxen
7. Azd-3582
8. Hct-3012
9. Ar-p900758xx
10. Azd 3582
11. V24gr4li3i
12. Chebi:76254
13. (s)-2-(6-methoxy-2-naphthyl)propanoic Acid 4-nitrooxybutyl Ester
14. 2-naphthaleneacetic Acid, 6-methoxy-alpha-methyl-, 4-(nitrooxy)butyl Ester, (alphas)-
15. 4-nitrooxybutyl (2s)-2-(6-methoxynaphthalen-2-yl)propanoate
16. 4-(nitrooxy)butyl (2s)-2-(6-methoxynaphthalen-2-yl)propanoate
17. 4-(nitrooxy)butyl (s)-2-(6-methoxynaphthalen-2-yl)propanoate
18. 4-(nitrooxy)butyl (2s)-2-(6-methoxy-2-naphthyl)propanoate
19. Naproxcinod [usan]
20. Naproxcinod [usan:inn]
21. Unii-v24gr4li3i
22. Naproxcinodum
23. Naproxcinod [mi]
24. Naproxcinod [inn]
25. Naproxcinod (usan/inn)
26. Naproxen Nitroxybutyl Ester
27. Naproxcinod [who-dd]
28. Gtpl9551
29. Schembl1170879
30. Chembl2103831
31. Dtxsid20167523
32. Zinc1541804
33. Akos015914063
34. Db06682
35. Me-0138
36. Zd-3582
37. Ac-23946
38. Hy-14931
39. Cs-0003642
40. D09568
41. E87348
42. Q3335996
43. 4-(nitrooxy)butyl(2s)-2-(6-methoxy-2-naphthyl)propanoate
44. 4-(nitrooxy)butyl-(2s)-2-(6-methoxy-2 Naphthyl)propanoate
45. (s)-2-(6-methoxy-2-naphtyl) Propionic Acid 4-nitrooxybutyl Ester
46. 2-naphthaleneacetic Acid, 6-methoxy-alpha-methyl-, 4-(nitrooxy)butyl Ester, (s)-
47. 2-naphthaleneacetic Acid, 6-methoxy-.alpha.-methyl-, 4-(nitrooxy)butyl Ester, (.alpha.s)-
Molecular Weight | 347.4 g/mol |
---|---|
Molecular Formula | C18H21NO6 |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 9 |
Exact Mass | 347.13688739 g/mol |
Monoisotopic Mass | 347.13688739 g/mol |
Topological Polar Surface Area | 90.6 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 438 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in pain (acute or chronic), inflammatory disorders (unspecified), osteoarthritis, and arthritis and arthritic pain.
Primary osteoarthritis
Nitric Oxide Donors
A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)
M - Musculo-skeletal system
M01 - Antiinflammatory and antirheumatic products
M01A - Antiinflammatory and antirheumatic products, non-steroids
M01AE - Propionic acid derivatives
M01AE18 - Naproxcinod
ABOUT THIS PAGE
A Naproxcinod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Naproxcinod, including repackagers and relabelers. The FDA regulates Naproxcinod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Naproxcinod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Naproxcinod supplier is an individual or a company that provides Naproxcinod active pharmaceutical ingredient (API) or Naproxcinod finished formulations upon request. The Naproxcinod suppliers may include Naproxcinod API manufacturers, exporters, distributors and traders.
Naproxcinod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Naproxcinod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Naproxcinod GMP manufacturer or Naproxcinod GMP API supplier for your needs.
A Naproxcinod CoA (Certificate of Analysis) is a formal document that attests to Naproxcinod's compliance with Naproxcinod specifications and serves as a tool for batch-level quality control.
Naproxcinod CoA mostly includes findings from lab analyses of a specific batch. For each Naproxcinod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Naproxcinod may be tested according to a variety of international standards, such as European Pharmacopoeia (Naproxcinod EP), Naproxcinod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Naproxcinod USP).
LOOKING FOR A SUPPLIER?